Analysis of interferon-beta therapy and certain miRNA levels in people with multiple sclerosis

Takeaway

  • MicroRNA miR-185-5p may serve as a novel biomarker for monitoring the response to interferon-beta (IFN-β) therapy in individuals with relapse-remitting multiple sclerosis (RRMS).

Why this matters

    The mechanism of IFN-β for treating individuals with RRMS remains unknown.